GlassScriptPhysician profile
Brandon Riemer
NPI 1548523715
$3,995.18
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,867 · 2020: $13.34 · 2021: $108 · 2022: $222 · 2023: $1,398 · 2024: $229 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,016 · Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,016.41 |
| Food and Beverage | $768.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,902.52 | 2019-2022 | |
| Biotissue Holdings INC. | $1,216.64 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $205.37 | 2020-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $185.15 | 2021-2025 | Clareon, Hydrus Microstent |
| Genentech USA, INC. | $110.95 | 2023-2025 | Vabysmo |
| Tarsus Pharmaceuticals, INC. | $78.02 | 2024 | Xdemvy |
| Sight Sciences, INC. | $47.31 | 2022-2024 | Omni Surgical System |
| Oyster Point Pharma, INC. | $41.76 | 2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $32.09 | 2025 | Xiidra |
| Ocular Therapeutix, INC. | $26.16 | 2022 | |
| Kala Pharmaceuticals, INC. | $24.49 | 2021 | |
| Aerie Pharmaceuticals, INC. | $23.50 | 2021 | |
| Dompe US, INC. | $19.79 | 2021 | |
| Biogen, INC. | $18.51 | 2022 | |
| Allergan, INC. | $17.81 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $17.24 | 2023 | Syfovre |
| Novartis Pharmaceuticals Corporation | $14.75 | 2022 | |
| New World Medical,INC. | $13.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Riemer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.